Results 11 to 20 of about 19,513 (261)
Frontiers in Immunology, 2021 IntroductionABO blood group antigens within grafts are continuously exposed to anti-A/B antibodies in the serum of recipients after ABO-incompatible (ABOi) kidney transplantation and are instrumental in antibody-mediated rejection.
Fan Zhang +19 more
doaj +1 more source
Kidney Research and Clinical Practice, 2016 Background: Kidney transplantation (KT) is the treatment of choice for end-stage renal disease patients. The spouse is a major donor in living KT. Clinical outcomes of spousal donor KT are not inferior to those of living related donor KT.
Woo Yeong Park +6 more
doaj +1 more source
Zhongguo shuxue zazhi, 2023 Objective To analyze ABO system hemolytic disease of the fetus and newborn (HDFN) and its influencing factors in Obstetrics Department of our hospital.
Shuling DONG +5 more
doaj +1 more source
Blood group incompatibility due to anti C antibody: a case report [PDF]
مجله علمی دانشگاه علوم پزشکی کردستان, 2018 Background and Aim: One of the main goals of blood transfusion medicine is to determine the compatibility of the blood products with the patients.
Mohsen Rajabnia Chenari +3 more
doaj +1 more source
Human Renal Homotransplantation in the Presence of Blood Group Incompatibilities. [PDF]
Experimental Biology and Medicine, 1963 Although red cell antigens are not thought to contribute to the homograft rejection process. there has been general insistence that human renal homografting should be restrieted to those cases in which the major blood groups are identical in the donor and recipient patients(1–3). Inasmuch as the red cell antigens are widely distributed in human tissues,
Starzl, TE, Marchioro, TL, Waddell, WR
openaire +2 more sources
A case of successful late steroid withdrawal after ABO-incompatible kidney transplantation
Korean Journal of Transplantation, 2020 Few data exist regarding steroid withdrawal in ABO-incompatible (ABO-i) kidney transplantation (KT). Here, we report a case of steroid withdrawal after ABO-i KT. A 46-year-old man diagnosed with Henoch-Schonlein purpura received ABO-i KT from his 42-year-
Jeong Min Cho +5 more
doaj +1 more source
Overcoming high pre-transplant isoagglutinin titers using high-dose intravenous immunoglobulin, salvage plasmapheresis, and booster rituximab without splenectomy in ABO-incompatible living donor liver transplantation: a case report [PDF]
Kosin Medical Journal, 2022 High pre-transplant isoagglutinin is a risk factor for antibody-mediated rejection in ABO-incompatible living donor liver transplantation. A 55-year-old man with alcoholic liver cirrhosis underwent ABO-incompatible living donor liver transplantation. The
Hyung Hwan Moon
doaj +1 more source
Transfusion reaction in a case with the rare Bombay blood group
Asian Journal of Transfusion Science, 2013 Bombay phenotype is extremely rare in Caucasian with an incidence of 1 in 250,000. When individuals with the Bombay phenotype need blood transfusion, they can receive only autologous blood or blood from another Bombay blood group. Transfusing blood group
Hayedeh Javadzadeh Shahshahani +2 more
doaj +1 more source
Трансплантология (Москва), 2018 Several protocols have been developed to overcome the blood group barrier in renal transplantation. In the evolution of these protocols, one of the latest steps was the combination of anti-CD20 treatment with antigen-specific immunoadsorption (IA) and ...
A. I. Sushkov, Ya. G. Moisyuk
doaj +1 more source
Transplantation Reports, 2017 Introduction: About 25% of the living donors analyzed for kidney donation are ABO incompatible, but ABO incompatibility can be successfully overcome by using various desensitization protocols.
Maria Cristina Ribeiro Castro +7 more
doaj +1 more source